Tech Company Financing Transactions

Elicio Therapeutics Funding Round

Elicio Therapeutics, based in Cambridge, raised investment capital from private investors.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Mailing Address
1 Kendall Sq. Building 1400 West 14303
Cambridge, MA 02139
Email Address
Elicio, based in Cambridge MA, is committed to transforming the lives of patients and their families by re-engineering the body's immune response to defeat cancer. By combining expertise in materials science and immunology, Elicio is engineering potent vaccines and immuno-therapies for an array of aggressive cancers.
Elicio Therapeutics LinkedIn Company Profile
Social Media
Elicio Therapeutics Company Twitter Account
Company News
Elicio Therapeutics News
Elicio Therapeutics on Facebook
Elicio Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Robert Connelly
  Robert Connelly LinkedIn Profile  Robert Connelly Twitter Account  Robert Connelly News  Robert Connelly on Facebook
Chief Medical Officer
Christopher Haqq
  Christopher Haqq LinkedIn Profile  Christopher Haqq Twitter Account  Christopher Haqq News  Christopher Haqq on Facebook
VP - Bus. Development
Charles Chase
  Charles Chase LinkedIn Profile  Charles Chase Twitter Account  Charles Chase News  Charles Chase on Facebook
VP - Bus. Development
Annette Matthies
  Annette Matthies LinkedIn Profile  Annette Matthies Twitter Account  Annette Matthies News  Annette Matthies on Facebook
VP - Operations
Michael DiVecchia
  Michael DiVecchia LinkedIn Profile  Michael DiVecchia Twitter Account  Michael DiVecchia News  Michael DiVecchia on Facebook
VP - Operations
Esther Welkowsky
  Esther Welkowsky LinkedIn Profile  Esther Welkowsky Twitter Account  Esther Welkowsky News  Esther Welkowsky on Facebook
VP - R & D
Peter DeMuth
  Peter DeMuth LinkedIn Profile  Peter DeMuth Twitter Account  Peter DeMuth News  Peter DeMuth on Facebook
VP - Regulatory Affairs
Nicole Hsu
  Nicole Hsu LinkedIn Profile  Nicole Hsu Twitter Account  Nicole Hsu News  Nicole Hsu on Facebook



Browse more venture capital transactions:

Prev: 3/28/2019: Meissa Vaccines venture capital transaction
Next: 3/28/2019: MineralTree venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary